已收盤 06-18 16:00:00 美东时间
+2.240
+1.56%
今日重点评级关注:Piper Sandler:维持Tenax Therapeutics"超配"评级,目标价从20美元升至50美元;Tigress Financial:维持优步"买入"评级,目标价从110美元升至115美元
06-15 08:32
Truist Securities analyst Richard Newitter maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $250 to $219.
06-12 22:17
Enhanced algorithm with new 100 mg/dL Target Glucose and improved alarm handling helps users improve time in range and stay in Automated Mode longerOmnipod 5 is now compatible with Abbott's Libre 3 Plus sensor in U.S.,
06-03 19:08
今日重点评级关注:Tigress Financial:维持英伟达"强力买入"评级,目标价从360美元升至425美元;康托·菲茨杰拉德:维持DeFi Development"超配"评级,目标价从6美元升至7美元
05-28 19:00
Redwire Corp涨25.82%;Intuitive Machines涨21.57%;联电涨13.76%
05-27 13:01
Insulet Corporation, Inc. (NASDAQ:PODD) ("Insulet" or the "Company") today announced a voluntary Medical Device Correction for specific lots of Omnipod® 5, Omnipod DASH®, and Omnipod® Insulin Management
05-27 04:10
The latest update is out from Insulet ( ($PODD) ). On May 20, 2026, Insulet Cor...
05-22 05:32
今日重点评级关注:TD Cowen:维持Strive"买入"评级,目标价从28美元升至30美元;蒙特利尔银行:维持KinderCare Learning"跑赢大市"评级,目标价从4美元升至6美元
05-19 10:55